1. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs)
   Masoumeh Eliyasi Dashtaki et al, 2023, Current Molecular Pharmacology CrossRef
2. Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy
   Kenneth K. W. To et al, 2024, Cancer Drug Resistance CrossRef
3. Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
   Liping Shan et al, 2020, Frontiers in Oncology CrossRef
4. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
   Jing Wen et al, 2020, Frontiers in Oncology CrossRef
5. Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
   Yujia Chen et al, 2022, Frontiers in Oncology CrossRef
6. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis
   Jianjun Zhao et al, 2023, Aging CrossRef
7. Linc00641 promotes the progression of gastric carcinoma by modulating the miR-429/Notch-1 axis
   Qun Hang et al, 2021, Aging CrossRef